Welcome to Markets Desk, here's what's moving the needle right now.
A federal judge has thrown a two-week roadblock in front of the Paramount and Warner Bros. Discovery merger, granting twelve states led by California more time to press their antitrust case. At eighty-one billion dollars, the deal would reshape Hollywood's media landscape, and regulators argue it would effectively extinguish competition in the streaming and content space.
Shifting to biotech, where Zhengye Biotechnology surged sharply after easing fears of a Nasdaq delisting, while Advanced Biomed caught a bid after pulling its planned securities offering — removing the dilution overhang that had been weighing on the stock. It was a choppy session in the sector, but these names found real buyers.
And in tech, Netflix's chief product and technology officer Elizabeth Stone is pushing what she calls AI fluency across the entire company, telling a podcast that the expectation of staff engaging meaningfully with artificial intelligence tools is now embedded in Netflix's culture. Notably, Stone also reaffirmed that junior talent remains a critical part of the firm's hiring strategy, pushing back against the notion that AI replaces entry-level roles.
That's the tape. Markets Desk, signing off the floor.
